DAVITA INC. SEC Filings

DaVita Inc. (DVA) director reports stock acquisition

A director of DaVita Inc. filed a Form 4 reporting the acquisition of 411 shares of common stock on 11/15/2025. The transaction is coded as an acquisition at a stated price of $0, which typically indicates a grant or similar award rather than an open-market purchase. Following this transaction, the reporting person beneficially owns 26,363 shares of DaVita common stock, held in direct ownership. The filing is made by a single reporting person and notes the individual’s role as a Director of the company.

DaVita Inc. (DVA) disclosed a Form 4 showing its Chief Executive Officer, who is also a director, had 5,165 shares of common stock withheld on 11/15/2025. These shares were withheld to cover tax obligations arising from the vesting of 12,474 restricted stock units, representing 33.333% of the original grant made on November 15, 2024. After this tax-withholding transaction, the reporting person directly beneficially owns 888,915 shares of DaVita common stock.

The Vanguard Group filed Amendment No. 14 to Schedule 13G reporting a passive stake in DaVita Inc. (DVA) as of 09/30/2025. Vanguard reported 4,227,904 shares beneficially owned, representing 5.91% of DaVita’s common stock.

Vanguard reported 0 shares with sole voting power and 214,553 with shared voting power. It reported 3,919,715 shares with sole dispositive power and 308,189 with shared dispositive power. The filing was made as an investment adviser (IA) and includes a certification that the securities are held in the ordinary course of business and not to change or influence control.

DaVita Inc. (DVA) insider filing reports a sale of 401,514 shares of common stock on 10/27/2025 at a price of $135.3558 per share. Following the transaction, the reporting persons collectively beneficially owned 31,759,065 shares, held indirectly.

Footnotes state that 15,126,977 shares are owned by Government Employees Insurance Company (a Berkshire Hathaway subsidiary). An additional 16,632,088 shares are held by pension plans: BNSF Master Retirement Trust 6,100,000 and Berkshire Hathaway Inc. Consolidated Pension Plan 10,532,088. The filing is signed “/s/ Warren E. Buffett” on behalf of the reporting persons.

DaVita Inc. filed its Q3 2025 10‑Q, reporting higher revenue and continued buybacks. Total revenues were $3,420,227 thousand, up from $3,263,590 thousand a year ago. Operating income was $505,767 thousand. Net income attributable to DaVita Inc. was $150,332 thousand, with diluted EPS of $2.04.

For the first nine months, revenues reached $10,023,282 thousand and net cash provided by operating activities was $1,345,774 thousand. The company repurchased 3,274 thousand shares in Q3 for $465,141 thousand and 10,001 thousand shares year‑to‑date for $1,461,387 thousand. As of October 28, 2025, approximately 70.6 million shares were outstanding.

DaVita issued $1,000,000 of 6.75% senior notes due 2033 and refinanced into a Term Loan B‑2 of $1,873,254; long‑term debt stood at $10,183,863 thousand. The weighted average effective interest rate on all debt was 5.70% in Q3. The company acquired Fresenius Medical Care’s Brazil dialysis operations for $94,282 thousand, contributing to total 2025 acquisition consideration of $108,015 thousand.

DaVita Inc. furnished an 8-K stating it issued a press release announcing financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1.

The information is being furnished under Item 2.02 and is not deemed “filed” for purposes of Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth. Additional materials include Exhibit 104.0 for the cover page Inline XBRL tags.

David Paul Maughan, Chief Operating Officer of DaVita Inc. (DVA), reported a transaction on 09/22/2025. The filing shows 7,501 shares of common stock were disposed of at a price of $130.16 per share through withholding to satisfy tax obligations. Those withheld shares represent 50% of 17,145 restricted stock units that vested for the reporting person from a grant dated September 22, 2022. After the withholding, the reporting person beneficially owns 122,266 shares. The form was signed by an attorney-in-fact on behalf of the reporting person.

DaVita Inc. reported that its board of directors has increased the authorization under its existing share repurchase program by an additional $2,000,000,000. This new repurchase authority is in addition to the amount remaining under the share repurchase program originally authorized on September 5, 2024, and it has no expiration date.

The company is not obligated to buy back any shares and may conduct repurchases in the open market or through privately negotiated transactions, including under its share repurchase agreement dated April 30, 2024 with Berkshire Hathaway Inc., as well as through accelerated share repurchases, derivatives, tender offers or Rule 10b5-1 plans. The timing and size of any repurchases will depend on market conditions, legal and contractual limits, and other factors, and DaVita can modify, suspend or discontinue the program at any time.

DaVita Inc. director Adam H. Schechter reported a non-derivative acquisition of company stock on 08/15/2025. The filing shows 369 shares were acquired with a reported price of $0, leaving the reporting person with 4,699 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or additional remarks are reported in the filing.